FIGURE 3.
Proliferation of gp12-treated mammalian cells in vitro. (A) Murine fibroblasts (BALB/3T3) treated with 1, 10, or 100 μg/ml of gp12 for 72 h. PBS served as a control. (B) Human skin microvascular endothelial cells (HSkMEC) treated with 1, 10, or 100 μg/ml of gp12 for 72 h. PBS served as a control.